Skip to content

Development and Validation of a Targeted Metabolomics Detection Method Based on UPLC-HRMS Technology

Development and Validation of a Targeted Metabolomics Detection Method Based on UPLC-HRMS Technology

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600124609
Enrollment
Unknown
Registered
2026-05-14
Start date
2026-01-20
Completion date
Unknown
Last updated
2026-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None

Interventions

Clinical validation group:Non

Sponsors

Wuxi children's hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
12 Years to 18 Years

Inclusion criteria

Inclusion criteria: 1.The experimental process can comply with relevant rules, age: 12–18 years old; 2.Good health, no history of severe chronic diseases or allergies; 3.Able to cooperate with examinations;

Exclusion criteria

Exclusion criteria: 1.Suffering from systemic diseases (such as diabetes, kidney disease, autoimmune diseases); 2.Receiving antibiotic treatment within 4 weeks; 3.Receiving hormone or immunosuppressant therapy within 6 months; 4.Presence of oral infections, gingivitis, periapical periodontitis, oral ulcers, acute pharyngitis, acute tonsillitis, or other oral diseases;

Design outcomes

Primary

MeasureTime frame
Method validation indicator;

Secondary

MeasureTime frame
Application Validation Metrics;

Countries

China

Contacts

Public ContactXu Xianyin

Wuxi children's hospital

imaginal_line@sina.com+86 133 0617 8180

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 22, 2026